FF Biotherapeutics
Revolutionizing Healthcare with Advanced Immunotherapy and Vaccine Development.
Discover our pioneering work in SSCP and MMPVs.
Meet Our Team
At FF Biotherapeutics, we are driven by a dedicated and visionary leadership team. Dr. Scott N. Freeman, PhD, our CEO and Co-Founder, is based in Massachusetts, US, and brings a wealth of experience in cancer biology, regulatory affairs, orphan drugs/rare diseases, molecular biology, biochemistry, cell biology, genetics, and experimental therapeutics. His extensive research and studies at Moffitt Cancer Center and the FDA as well as time in the pharmaceutical industry and consulting have paved the way for the development of our groundbreaking treatments. Joining him is Dr. Ingo Fricke, MS, PhD, our CSO and Co-Founder, who is based in Germany. With expertise in immunology, tumor biology, cancer biology, chemistry, and an extensive publication record, Dr. Fricke has been instrumental in shaping our innovative product pipeline. Together, our leadership team is committed to driving positive change and delivering transformative solutions to address serious diseases of unmet need.
Name: Dr. Scott N. Freeman, PhD
Role: CEO & Co-Founder
Bio: Dr. Scott N. Freeman, the dynamic force behind FF Biotherapeutics, exemplifies a blend of creativity, determination, and visionary leadership. A music aficionado from a young age, he mastered the electric guitar by age 12 and played in various bands across Michigan. His musical journey took him to Germany, where he deepened his skills in bass guitar, drumming, audio mixing, and production, eventually leading to the establishment of his own music studio.
Beyond the musical realm, Dr. Freeman is a passionate swimmer, averaging an impressive 4 miles weekly, reflecting his commitment to a balanced lifestyle of art and athleticism.
At the heart of his world are his two boys, with whom he shares his diverse interests, fostering a close-knit family bond.
In his professional role at FF Biotherapeutics, Dr. Freeman integrates his diverse experiences and creative energy to drive innovative healthcare solutions, impacting lives globally with a focus on improving patient outcomes.
Name: Dr. Ingo Fricke, MS, PhD
Role: CSO & Co-Founder
Bio: Dr. Ingo Fricke, with his profound expertise in immunology, tumor biology, and chemistry, serves as the Chief Scientific Officer at FF Biotherapeutics. As a co-founder, Dr. Fricke has been instrumental in shaping the company's scientific vision and research direction. With an extensive background in biological sciences, he has played a pivotal role in the development of FF Biotherapeutics' groundbreaking immunotherapy and vaccine technologies.
His contributions to the company's innovative product pipeline reflect his deep understanding of disease mechanisms and his commitment to advancing healthcare solutions. Dr. Fricke's leadership in the research team is marked by a blend of scientific rigor and creative problem-solving, driving the company's efforts in addressing some of the most challenging health issues.
Under Dr. Fricke's guidance, FF Biotherapeutics continues to explore new frontiers in biotechnology, making significant strides in the field of immunotherapy and vaccine development.
